Outokumpu Oyj (LON:0FJ8)
London · Delayed Price · Currency is GBP · Price in EUR 3.784
-0.098 (-2.54%)
At close: Oct 30, 2025
Outokumpu Oyj Revenue
Outokumpu Oyj had revenue of 1.30B EUR in the quarter ending September 30, 2025, a decrease of -14.49%. This brings the company's revenue in the last twelve months to 5.71B, down -5.59% year-over-year. In the year 2024, Outokumpu Oyj had annual revenue of 5.94B, down -14.64%.
Revenue (ttm)
5.71B EUR
Revenue Growth
-5.59%
P/S Ratio
0.30
Revenue / Employee
653.96K EUR
Employees
8,736
Market Cap
1.50B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.94B | -1.02B | -14.64% |
| Dec 31, 2023 | 6.96B | -2.53B | -26.68% |
| Dec 31, 2022 | 9.49B | 2.25B | 31.08% |
| Dec 31, 2021 | 7.24B | 1.60B | 28.44% |
| Dec 31, 2020 | 5.64B | -764.00M | -11.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |